Recombinant LIV-1 (Ladiratuzumab Biosimilar) antibody

Catalog No. ABIN7597769

This anti-LIV-1 (Ladiratuzumab Biosimilar) antibody is a Humanized Chimeric antibody detecting LIV-1 (Ladiratuzumab Biosimilar) in . Suitable for Human.

Quick Overview for Recombinant LIV-1 (Ladiratuzumab Biosimilar) antibody (ABIN7597769)

Target: LIV-1 (Ladiratuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This LIV-1 (Ladiratuzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-LIV-1 (Ladiratuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Ladiratuzumab Biosimilar Antibody

Specificity: SLC39A6, LIV1, Zrt- and Irt-like protein 6, Zinc transporter ZIP6, ZIP-6, Estrogen-regulated protein LIV-1, Solute carrier family 39 member 6, ZIP6

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for LIV-1 (Ladiratuzumab Biosimilar)

Target: LIV-1 (Ladiratuzumab Biosimilar)

Alternative Name: Ladiratuzumab Biosimilar

Target Type: Biosimilar

Background: SLC39A6, LIV1, Zrt- and Irt-like protein 6, Zinc transporter ZIP6, ZIP-6, Estrogen-regulated protein LIV-1, Solute carrier family 39 member 6, ZIP6

UniProt: Q13433

CAS-No: 1629760-28-6